This inventor holds 1 USPTO granted patent. Top assignee: Monoclonal Antibodies Therapeutics “m.a.t.”. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Rafael Levy: Innovator in Cancer Treatment
Introduction
Rafael Levy is a notable inventor based in Montrouge, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies.
Latest Patents
Rafael Levy holds a patent for the "Use of anti-ferritin monoclonal antibodies in the treatment of some cancers." This invention focuses on the use of an anti-ferritin monoclonal antibody or a fragment thereof in preparing a medicine for treating cancer cells that exhibit overexpression of a product of a gene from the myc-related family. The antibody identifies an epitope common to both acidic and basic human ferritins, showcasing a targeted approach to cancer therapy.
Career Highlights
Levy is associated with Monoclonal Antibodies Therapeutics, a company dedicated to advancing therapeutic solutions through monoclonal antibody technology. His work has positioned him as a key figure in the development of innovative cancer treatments.
Collaborations
Rafael Levy collaborates with Jean Kadouche, contributing to the advancement of their shared goals in the field of cancer research and treatment.
Conclusion
Rafael Levy's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work continues to inspire advancements in the field of oncology.